Herpes Zoster (HZ)
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
BioTherapeutics IncVA - Blacksburg
2 programs1
1
JCXH-105Phase 21 trial
JCXH-105Phase 11 trial
Active Trials
GSKLONDON, United Kingdom
1 programObesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic NeuralgiaN/A1 trial
Active Trials
ViiV HealthcareNC - Durham
1 programObesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic NeuralgiaN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
BioTherapeutics IncJCXH-105
BioTherapeutics IncJCXH-105
GSKObesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic Neuralgia
Clinical Trials (3)
Total enrollment: 200,542 patients across 3 trials
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
Start: Oct 2024Est. completion: Aug 2026467 patients
Phase 2Active Not Recruiting
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
Start: May 2023Est. completion: Mar 202475 patients
Phase 1Completed
NCT06638177GSKObesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic Neuralgia
Obesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic Neuralgia
Start: Jun 1976Est. completion: Dec 2027200,000 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.